©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.111454
Figure 13 SLC39A14 is regulated by the transcription factor STAT3.
A: Bioinformatics analysis identified STAT3 as one of potential transcription factor driving SLC39A14 expression; B and C: Binding sites for STAT3 in the promoter region of SLC39A14 were identified according to the JASPAR website; D: Pearson’s correlational analysis was performed to explore the correlation between the mRNA levels of STAT3 and SLC39A14 in hepatocellular carcinoma patients in The Cancer Genome Atlas dataset (r = 0.41, P < 0.0001).
- Citation: Guo W, Wang MX, Mu T, Xu K, Jiang ZD, Wan XH, Li JW, Yi YX. Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 111454
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/111454.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.111454